- Home
- EIG vs IMCR Comparison
EIG vs IMCR Comparison
Compare EIG & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- IMCR
- Stock Information
- Founded
- EIG 2000
- IMCR 2008
- Country
- EIG United States
- IMCR United Kingdom
- Employees
- EIG N/A
- IMCR N/A
- Industry
- EIG Property-Casualty Insurers
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EIG Finance
- IMCR Health Care
- Exchange
- EIG Nasdaq
- IMCR Nasdaq
- Market Cap
- EIG 1.3B
- IMCR 1.5B
- IPO Year
- EIG 2007
- IMCR 2021
- Fundamental
- Price
- EIG $50.02
- IMCR $29.86
- Analyst Decision
- EIG Strong Buy
- IMCR Buy
- Analyst Count
- EIG 1
- IMCR 13
- Target Price
- EIG $58.00
- IMCR $65.18
- AVG Volume (30 Days)
- EIG 139.9K
- IMCR 330.4K
- Earning Date
- EIG 02-13-2025
- IMCR 02-26-2025
- Dividend Yield
- EIG 2.40%
- IMCR N/A
- EPS Growth
- EIG 20.58
- IMCR N/A
- EPS
- EIG 5.34
- IMCR N/A
- Revenue
- EIG $889,800,000.00
- IMCR $296,312,000.00
- Revenue This Year
- EIG N/A
- IMCR $29.19
- Revenue Next Year
- EIG $1.18
- IMCR $12.56
- P/E Ratio
- EIG $9.36
- IMCR N/A
- Revenue Growth
- EIG 5.05
- IMCR 25.09
- 52 Week Low
- EIG $38.38
- IMCR $27.69
- 52 Week High
- EIG $54.44
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- EIG 37.65
- IMCR 47.47
- Support Level
- EIG $50.34
- IMCR $28.37
- Resistance Level
- EIG $51.30
- IMCR $30.42
- Average True Range (ATR)
- EIG 0.85
- IMCR 1.36
- MACD
- EIG -0.18
- IMCR 0.17
- Stochastic Oscillator
- EIG 3.67
- IMCR 69.11
About EIG Employers Holdings Inc
Employers Holdings Inc provides workers' compensation insurance, to small businesses in low- to medium-hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through itswholly owned subsidiaries.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.